Start Your Health Journey

Scientific Articles

SCIENTIFIC ARTICLES AND US PATENTS ON ACTUAL BIOVED PRODUCTS AND TECHNOLOGY

  1. Chitre D. (2024) Ayurveda: Bridging innovation for human and animal health. J Res Ayurvedic Sci 2024;8:9-11. DOI: 10.4103/jras.jras_83_23. Ayurveda: Bridging innovation for human and animal health.
  2. Chitre et al. (2023) United States Patent. Methods and Formulations for Treating and Preventing Long Haul Coronavirus (Long-COVID) Symptoms and Sequelae, Pub. No.:US 2023/0226082 AI. July 20, 2023. Methods and Formulations for Treating and Preventing Long Haul Coronavirus (Long-COVID) Symptoms and Sequelae,
  3. Chitre et al (2023) United States Patent. Methods and Compounds for Treating Effects of Covid-19 disease. Patent No.: US 11,628,197 B2. April 18, 2023. United States Patent. Methods and Compounds for Treating Effects of Covid-19 disease,
  4. Bhatt N., Johnson J., Chaskar S. and Chitre D. (2023) Randomized Clinical Trial of an Ayurvedic Formulation, BV-7310 in Alcoholic Liver Disease. Indian Journal of Clinical Practice, February 2023; Vol. 33, No. 9. Randomized Clinical Trial of an Ayurvedic Formulation, BV-7310 in Alcoholic Liver Disease.
  5. Chitre D. et al. (2022). Phase III randomized clinical trial of BV-4051, an Ayurvedic polyherbal formulation in moderate SARS-CoV-2 infections and its impact on inflammatory biomarkers. Phytotherapy Research, 1–10. https://doi.org/10.1002/ptr.7683. Randomized Clinical Trial of an Ayurvedic Formulation, BV-7310 in Alcoholic Liver Disease.
  6. Bhatt N., Deshpande M., Chaskar S. (2020) A Critical Review of Standardization of Ayurvedic Dosage Form Kwatha – Part – II: Approaches and Outcome. Ind J of Ayu Med. Vol 11 (3), 378-386. A Critical Review of Standardization of Ayurvedic Dosage Form Kwatha – Part – II: Approaches and Outcome.
  7. Chopra A, Saluja M, Kianifard T, Chitre D, Venugopalan (2018) Long term effectiveness of RA- 1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis. J Ayurveda Integr Med. 9(3):201-208. DOI: 10.1016/j.jaim.2017.07.009. Long term effectiveness of RA- 1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis.
  8. Dey D, Chaskar S, Bhatt N, Chitre D. (2020) Hepatoprotective Activity of BV-7310, a Proprietary Herbal Formulation of Phyllanthus niruri, Tephrosia purpurea, Boerhavia diffusa,and Andrographis paniculata, in Alcohol-Induced HepG2 Cells and Alcohol plus a Haloalkane, CCl4, Induced Liver Damage in Rats. Evid Based Complement Alternat Med. DOI: 10.1155/2020/6428906. Hepatoprotective Activity of BV-7310, a Proprietary Herbal Formulation of Phyllanthus niruri, Tephrosia purpurea, Boerhavia diffusa, and Andrographis paniculata, in Alcohol-Induced HepG2 Cells and Alcohol plus a Haloalkane, CCl4, Induced Liver Damage in Rats.
  9. Dey D, Chaskar S, Athavale N, Chitre D. (2015) Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation. Biomed Res Int. DOI: 10.1155/2015/971982. Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation.
  10. Chitre et al. (2014) United States Patent. Synergistic Formulation of Plant Extracts for Hepatic and Adrenal Disorders. Pub. No.: US 2014/0363526 AI. Dec 11, 2014. Synergistic Formulation of Plant Extracts for Hepatic and Adrenal Disorders,
  11. Dey D., Chaskar S., Athavale N., Chitre D. (2014) Inhibition of LPS-Induced TNF-α and NO Production in Mouse Macrophage and Inflammatory Response in Rat Animal Models by a Novel Ayurvedic Formulation, BV-9238. Phytother Res. 28(10):1479-85. Inhibition of LPS-Induced TNF-α and NO Production in Mouse Macrophage and Inflammatory Response in Rat Animal Models by a Novel Ayurvedic Formulation, BV-9238.
  12. Chitre et al. (2014) US Patent. Method for extraction of Fractions containing Pharmacologically Active Ingredients with less Cytotoxicity from one or more Plants. Patent No.: US 8,808,769 B2. Aug 19, 2014. Method for extraction of Fractions containing Pharmacologically Active Ingredients with less Cytotoxicity from one or more Plants.
  13. Chopra A., Saluja M. (2012) Validation and usefulness of Indian version (CRD Pune) health assessment questionnaire: Drug trials, community practice and COPCORD Bhigwan population study (1994-2012) Indian Journal of Rheumatology. Vol 7, Number 2; pp. 74-82. Validation and usefulness of Indian version (CRD Pune) health assessment questionnaire: Drug trials, community practice and COPCORD Bhigwan population study (1994-2012).
  14. Chitre et al. (2010) US Patent. Novel Formulations to Inhibit Cyclooxygenase and Pro-Inflammatory Cytokine Mediated Diseases. Pub. No.: US 2010/0150865 AI. Jun 17, 2010. Novel Formulations to Inhibit Cyclooxygenase and Pro-Inflammatory Cytokine Mediated Diseases.
  15. Chopra A., Saluja M., Tillu G. (2010) Ayurveda – modern medicine interface: A critical appraisal of studies of Ayurvedic medicine to treat osteoarthritis and rheumatoid arthritis. J Ayurveda Integr Med. 1(3): 190–198. PMC3087360. Ayurveda – modern medicine interface: A critical appraisal of studies of Ayurvedic medicine to treat osteoarthritis and rheumatoid arthritis.
  16. Wadnap N., Johnson J., Bhatt N. and Chitre D. (2006) Efficacy and safety of RA-11 (O) – a herbal analgesic cream. Indian J of Trad know. Vol 5 (3) July 2006, pp 384-387. Efficacy and safety of RA-11 (O) – a herbal analgesic cream.
  17. Patwardhan B, Warude D., Pushpangadan P., Bhatt N. (2005) Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med. 2(4):465-73. Epub 2005 Oct PMC1297513. Ayurveda and traditional Chinese medicine: a comparative overview
  18. Diwanay S., Chitre D., Patwardhan B. (2004) Immunoprotection by botanical drugs in cancer chemotherapy. J Ethno Pharm. 90:1. 49-50. DOI:10.1016/j.jep.2003.09.023. Immunoprotection by botanical drugs in cancer chemotherapy.
  19. Chopra A, Lavin, Patwardhan & Chitre. (2004) Randomized Double-Blind Placebo-Controlled Trial of Efficacy and Safety, in particular VAS and WOMAC, in Osteoarthritis of Knee (Journal of Clinical Rheumatology.10:236-245), DOI: 10.1097/01.rhu.0000138087.47382.6d. Randomized Double-Blind Placebo-Controlled Trial of Efficacy and Safety, in particular VAS and WOMAC, in Osteoarthritis of Knee.
  20. Chopra A., (2000) Ayurvedic Medicine and Arthritis, Rheumatic Disease Clinics of North America: Vol 26 (1) DOI: 10.1016/s0889-857x(05)70127-7. Ayurvedic Medicine and Arthritis.
  21. Judith Horstman. (2000) “These ancient Indian remedies are said to ease aches and inflammation. A new study prompted us to take a closer look.” Arthritis Today (Publication of The Arthritis Foundation).
  22. Chopra A., Lavin P., Patwardhan B. and Chitre D. (2000) Randomized Double-Blind Placebo-Controlled Trial of Efficacy and Safety in Rheumatoid Journal of Rheumatology, 27:1365-72 PMID: 10852255. Randomized Double-Blind Placebo-Controlled Trial of Efficacy and Safety in Rheumatoid Arthritis.
  23. (1996) United States Patent. Method of treating musculoskeletal disease and a novel composition therefor. Patent No.: 5,494,668 Feb 27, 1996. Method of treating musculoskeletal disease and a novel composition therefor.

Contact us

North Americas

South Americas

Asia

South East Asia

Scroll to Top